Octreotide recalls

The FDA has published 11 recalls involving Octreotide since 2012. The latest was reported on 13 May 2026. Most were for sterility. Teva Pharmaceuticals USA has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls11since 2012

Last 12 months4reported

Class I19% of total

Ongoing4latest 13 May 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 3Apr 1 0 0Jul 0 0

Severity split

Class I 1 9%Class II 10 91%Class III 0 0%

Why octreotide is recalled

Companies

By year

2026436%
202219%
2021327%
2016218%
201219%

Ongoing octreotide recalls

4 active

Reported	Class	Recall	Company	Reason	Where
13 May 2026Drug	CLASS II	Octreotide Acetate for Injectable Suspension recalledOctreotide Acetate	Teva Pharmaceuticals USA	Sterility	Nationwide
1 Apr 2026Drug	CLASS II	Octreotide Acetate for Injectable Suspension recalledOctreotide Acetate	Teva Pharmaceuticals USA	Sterility	Nationwide
1 Apr 2026Drug	CLASS II	Octreotide Acetate for Injectable Suspension recalledOctreotide Acetate	Teva Pharmaceuticals USA	Sterility	Nationwide
1 Apr 2026Drug	CLASS II	Octreotide Acetate for Injectable Suspension recalledOctreotide Acetate	Teva Pharmaceuticals USA	Sterility	Nationwide

All octreotide recalls, newest first

11 total

Reported	Class	Recall	Company	Reason	Where
13 May 2026Drug	CLASS II	Octreotide Acetate for Injectable Suspension recalledOctreotide Acetate	Teva Pharmaceuticals USA	Sterility	Nationwide
1 Apr 2026Drug	CLASS II	Octreotide Acetate for Injectable Suspension recalledOctreotide Acetate	Teva Pharmaceuticals USA	Sterility	Nationwide
1 Apr 2026Drug	CLASS II	Octreotide Acetate for Injectable Suspension recalledOctreotide Acetate	Teva Pharmaceuticals USA	Sterility	Nationwide
1 Apr 2026Drug	CLASS II	Octreotide Acetate for Injectable Suspension recalledOctreotide Acetate	Teva Pharmaceuticals USA	Sterility	Nationwide
16 Nov 2022Drug	CLASS I	Octreotide Acetate Injection 500 mcg/mL recalled by ViatrisOctreotide Acetate	Viatris	Particulate Matter	Nationwide
25 Aug 2021Drug	CLASS II	Octreotide Acetate Injection 50 mcg/mL single-dose vial recalled	Teva Pharmaceuticals U	Sterility	Nationwide
25 Aug 2021Drug	CLASS II	Octreotide Acetate Injection 100 mcg/mL single-dose vial recalled	Teva Pharmaceuticals U	Sterility	Nationwide
25 Aug 2021Drug	CLASS II	Octreotide Acetate Injection 1000 mcg/ multi-dose vial recalled	Teva Pharmaceuticals U	Sterility	Nationwide
1 Jun 2016Drug	CLASS II	Octreotide Acetate Injection, 50 mcg recalled by Fresenius Kabi USA	Fresenius Kabi USA	Potency & Assay	Nationwide
1 Jun 2016Drug	CLASS II	Octreotide Acetate Injection, 50 mcg recalled by Fresenius Kabi USA	Fresenius Kabi USA	Potency & Assay	Nationwide

Should you stop taking Octreotide?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.